PointState Capital’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-41,554
| Closed | -$66.2M | – | 172 |
|
|
2018
Q1 | $66.2M | Sell |
41,554
-220,157
| -84% | -$351M | 0.72% | 40 |
|
|
2017
Q4 | $234M | Buy |
261,711
+156,358
| +148% | +$140M | 2.28% | 11 |
|
|
2017
Q3 | $37.9M | Sell |
105,353
-10,047
| -9% | -$3.62M | 0.32% | 64 |
|
|
2017
Q2 | $33.8M | Buy |
115,400
+85,167
| +282% | +$25M | 0.37% | 52 |
|
|
2017
Q1 | $10.6M | Buy |
+30,233
| New | +$10.6M | 0.11% | 89 |
|
|
2016
Q4 | – | Sell |
-36,667
| Closed | -$9.45M | – | 144 |
|
|
2016
Q3 | $9.45M | Buy |
36,667
+23,334
| +175% | +$6.01M | 0.1% | 86 |
|
|
2016
Q2 | $2.85M | Buy |
+13,333
| New | +$2.85M | 0.06% | 78 |
|
|
2016
Q1 | – | Sell |
-6,667
| Closed | -$1.69M | – | 102 |
|
|
2015
Q4 | $1.69M | Buy |
+6,667
| New | +$1.69M | 0.04% | 75 |
|
|
2015
Q2 | – | Sell |
-40,000
| Closed | -$6.6M | – | 156 |
|
|
2015
Q1 | $6.6M | Sell |
40,000
-26,667
| -40% | -$4.4M | 0.09% | 87 |
|
|
2014
Q4 | $15.5M | Buy |
+66,667
| New | +$15.5M | 0.26% | 68 |
|
|
2013
Q4 | – | Sell |
-38,333
| Closed | -$6.01M | – | 156 |
|
|
2013
Q3 | $6.01M | Buy |
+38,333
| New | +$6.01M | 0.1% | 89 |
|